Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic retroviral vectors for gene therapy

Therapeutic retroviral vectors for gene therapy

US Patent 10632212 · Granted Apr 28, 2020

Estimated economic value: $37,972,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic retroviral vectors for gene therapy2023
Therapeutic retroviral vectors for gene therapy2023
Therapeutic retroviral vectors for gene therapy2023
Gene therapy methods2019
Therapeutic retroviral vectors for gene therapy2018
Therapeutic retroviral vectors for gene therapy2018
Therapeutic retroviral vectors for gene therapy2018
Gene therapy methods2017
Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a STA2017
Therapeutic retroviral vectors for gene therapy2015
Therapeutic retroviral vectors for gene therapy2015
Therapeutic retroviral vectors for gene therapy2015